期刊文献+

糖尿病肾病患者血清胱抑素C及AFU联合检测的临床意义 被引量:5

下载PDF
导出
摘要 糖尿病是一组病因和发病机制尚未完全阐明的内分泌代谢性疾病,而糖尿病肾病(DN)是糖尿病微血管病变的严重并发症,早期肾损害是引起糖尿病患者病死的主要原因之一。因此DN的早期发现和早期治疗对延缓肾功能的恶化,提高患者的生存率显得非常重要。
出处 《标记免疫分析与临床》 CAS 2014年第3期347-348,共2页 Labeled Immunoassays and Clinical Medicine
  • 相关文献

参考文献6

  • 1Fliser D, Ritz E. Serum cystain C concentration as marker of renal dysfunction in the elderly. Am J Kidney Dis ,2001,37 (1) :79-83.
  • 2李晓娟.胱氨酸蛋白酶抑制剂C的临床应用[J].国外医学(临床生物化学与检验学分册),2004,25(1):6-7. 被引量:64
  • 3孔岩,杨建梅,徐国宾,李淑葵,张春丽,郭晓蕙.对2型糖尿病患者肾小球滤过功能的评价[J].中华检验医学杂志,2007,30(11):1219-1222. 被引量:39
  • 4Boer I H, Katz R, Cao J J, et al. Cystatin C, albuminuria and mortality among older adults with diabetes. Diabetes Care, 2009,32 ( 10 ) : 1833-1838.
  • 5E1-Shatey E M,E1-Nagar G F,Selim M F,et al. Is serum Cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus. Ren Fail,2009,31 (5) :355-359.
  • 6Sakaguchi S, Tanaka A, Kawanishi T, et al. Comparison between serum cystatin C and estimation of GFR by the MDRD study equation for chronic kidney disease. Nihon Jinzo Gakkai Shi, 2008,50 ( 8 ) : 1011-1016.

二级参考文献11

  • 1张春丽,李乾,左力,崔盈,王彦福,郭凤琴,赵光宇,张旭初,周玉红,王荣福.肾动态显像法与双血浆法测定肾小球滤过率的对比分析[J].北京大学学报(医学版),2004,36(6):612-615. 被引量:32
  • 2李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 3Andersen JK,Schmidt C,Nordin G.Serum cystatin C.determined by a rapid,automated particle-enhanced turbidimetric method,is a better marker than serum cretinine for glomerular filtration rate.Clin Chem,1994,40(10):1921-1926.
  • 4Randers E,Erlandsen EJ.Serum cystatin C as endogenous marker of the renal function-a review.ClinChem Lab Med,1999,37(4):389-395.
  • 5keevil GB,Kilpatrick ES,Nichols SP,et al.Biological variation of cystatin C:implication for the assessnent of glomerular filtration rate.Clin chem.1998,44(7):1535-1539.
  • 6Finney H,Newman DJ,Gruber W.Initial evaluatin of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA,BN Ⅱ).Clin Chem,1997,43(6):1016-1020.
  • 7Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med, 1996,37 : 1883-1890.
  • 8Finer G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem, 2005,38 : 1-8
  • 9Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin c and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest, 2005,65 : 111-124.
  • 10Eknoyan G, Levin N. NKF-K/DOQI Clinical Practice Guideline: Update 2000 Foreward. Am J Kidney Dis, 2001, 37 :S5-S6.

共引文献91

同被引文献39

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部